Skip to content

Covered Versus Uncovered Biliary Stents for Biliary Malignancies

Covered Versus Uncovered Metal Stents for Biliary Malignancies - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02102984
Enrollment
140
Registered
2014-04-03
Start date
2014-04-30
Completion date
2015-12-31
Last updated
2016-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Tract Cancer

Keywords

distal malignancy of the extra-hepatic biliary tract, metallic biliary stents, covered biliary stents, uncovered biliary stents

Brief summary

Patency duration of covered metal stents as compared with uncovered metal stents in the management of malignant strictures of the extra-hepatic biliary tree.

Detailed description

Consecutive patients with malignant strictures of the extra-hepatic biliary tree considered unfit for surgical excision Placement of covered or uncovered metal stents in patients with and without gallbladder on the basis of a computer-generated randomization list Evaluation of clinical outcome, survival, complications, and quality of life. Evaluation of the cost and efficacy of the two types of metal stents.

Interventions

DEVICEcovered biliary stents

endoscopic placement of covered biliary stents

DEVICEuncovered biliary stents

endoscopic placement of uncovered biliary stents

Sponsors

Nuovo Ospedale Civile S.Agostino Estense
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients with symptomatic malignant obstruction of the extra-hepatic biliary tree * not eligible for surgical intervention * able to provide informed consent

Exclusion criteria

* benign biliary obstruction * previous surgery of the biliary tract * life expectancy \< 3 months

Design outcomes

Primary

MeasureTime frameDescription
Relief of malignant biliary obstructionsix monthsClinical assessment

Secondary

MeasureTime frameDescription
cost/effecacy6 monthscost and effectiveness of covered versus uncovered biliary stents

Other

MeasureTime frameDescription
gallbladder in situ6 monthsAcute cholecystitis could affect the clinical outcome of patients when a covered stent is used

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026